These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34053779)

  • 1. Magnetic Resonance Imaging for Tailoring the Need to Biopsy During Follow-up for Men on Active Surveillance for Prostate Cancer.
    Padhani AR; Rouvière O; Schoots IG
    Eur Urol; 2021 Nov; 80(5):564-566. PubMed ID: 34053779
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
    Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
    BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer.
    Sathianathen NJ; Konety BR; Alarid-Escudero F; Lawrentschuk N; Bolton DM; Kuntz KM
    Eur Urol; 2019 Jun; 75(6):910-917. PubMed ID: 30425010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up.
    Klotz L; Pond G; Loblaw A; Sugar L; Moussa M; Berman D; Van der Kwast T; Vesprini D; Milot L; Kebabdjian M; Fleshner N; Ghai S; Chin J; Haider M
    Eur Urol; 2020 Mar; 77(3):311-317. PubMed ID: 31708295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmatory Magnetic Resonance Imaging with or without Biopsy Impacts Decision Making in Newly Diagnosed Favorable Risk Prostate Cancer.
    Ginsburg KB; Arcot R; Qi J; Linsell SM; Kaye DR; George AK; Cher ML;
    J Urol; 2019 May; 201(5):923-928. PubMed ID: 30694939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions.
    Loeb S; Zhou Q; Siebert U; Rochau U; Jahn B; Mühlberger N; Carter HB; Lepor H; Braithwaite RS
    Eur Urol; 2017 Dec; 72(6):899-907. PubMed ID: 28844371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.
    Recabal P; Assel M; Sjoberg DD; Lee D; Laudone VP; Touijer K; Eastham JA; Vargas HA; Coleman J; Ehdaie B
    J Urol; 2016 Aug; 196(2):374-81. PubMed ID: 26920465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.
    Hamoen EHJ; Hoeks CMA; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Bokhorst LP; Witjes JA; Rovers MM; Hulsbergen-van de Kaa CA; Barentsz JO
    Eur Urol Focus; 2019 May; 5(3):407-415. PubMed ID: 29331622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance.
    Chesnut GT; Vertosick EA; Benfante N; Sjoberg DD; Fainberg J; Lee T; Eastham J; Laudone V; Scardino P; Touijer K; Vickers A; Ehdaie B
    Eur Urol; 2020 Apr; 77(4):501-507. PubMed ID: 31874726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Imaging Should Be Used in the Active Surveillance of Patients with Localised Prostate Cancer.
    Kasivisvanathan V; Giganti F; Emberton M; Moore CM
    Eur Urol; 2020 Mar; 77(3):318-319. PubMed ID: 31780103
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply?
    Hu JC; Chang E; Natarajan S; Margolis DJ; Macairan M; Lieu P; Huang J; Sonn G; Dorey FJ; Marks LS
    J Urol; 2014 Aug; 192(2):385-90. PubMed ID: 24512956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric MRI in Active Surveillance of Prostate Cancer: An Overview and a Practical Approach.
    Lee CH; Tan TW; Tan CH
    Korean J Radiol; 2021 Jul; 22(7):1087-1099. PubMed ID: 33856136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts in multiparametric magnetic resonance imaging for active surveillance of prostate cancer.
    Cavalcante A; Viana PCC; Guglielmetti GB; Pontes Junior J; Nonemacher H; Cordeiro MD; Bezerra ROF; Coelho RF; Nahas WC
    Clinics (Sao Paulo); 2018 Dec; 73(suppl 1):e464s. PubMed ID: 30540118
    [No Abstract]   [Full Text] [Related]  

  • 14. Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy.
    Bloom JB; Hale GR; Gold SA; Rayn KN; Smith C; Mehralivand S; Czarniecki M; Valera V; Wood BJ; Merino MJ; Choyke PL; Parnes HL; Turkbey B; Pinto PA
    J Urol; 2019 Jan; 201(1):84-90. PubMed ID: 30577395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value.
    Felker ER; Wu J; Natarajan S; Margolis DJ; Raman SS; Huang J; Dorey F; Marks LS
    J Urol; 2016 May; 195(5):1421-1427. PubMed ID: 26674305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restriction Spectrum Imaging-Magnetic Resonance Imaging to Improve Prostate Cancer Imaging in Men on Active Surveillance.
    Besasie BD; Sunnapwar AG; Gao F; Troyer D; Clarke GD; White H; Fox PT; Dale A; Wheeler A; Liss MA
    J Urol; 2021 Jul; 206(1):44-51. PubMed ID: 33617334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regular transition zone biopsy during active surveillance for prostate cancer may improve detection of pathological progression.
    Wong LM; Toi A; Van der Kwast T; Trottier G; Alibhai SM; Timilshina N; Evans A; Zlotta A; Fleshner N; Finelli A
    J Urol; 2014 Oct; 192(4):1088-93. PubMed ID: 24742593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate Indeterminate Lesions on Magnetic Resonance Imaging-Biopsy Versus Surveillance: A Literature Review.
    Gómez Rivas J; Giganti F; Álvarez-Maestro M; Freire MJ; Kasivisvanathan V; Martinez-Piñeiro L; Emberton M
    Eur Urol Focus; 2019 Sep; 5(5):799-806. PubMed ID: 29525382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated clinical results of active surveillance of very-low-risk prostate cancer in Korean men: 8 years of follow-up.
    Ha JY; Shin TJ; Jung W; Kim BH; Park CH; Kim CI
    Investig Clin Urol; 2017 May; 58(3):164-170. PubMed ID: 28480341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric Magnetic Resonance Imaging Is Associated with Increased Medicare Spending in Prostate Cancer Active Surveillance.
    Macleod LC; Yabes JG; Fam MM; Bandari J; Yu M; Maganty A; Furlan A; Filson CP; Davies BJ; Jacobs BL
    Eur Urol Focus; 2020 Mar; 6(2):242-248. PubMed ID: 31031042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.